- freely available
Viruses 2013, 5(8), 2005-2018; doi:10.3390/v5082005
Published: 15 August 2013
Abstract: Caprine arthritis encephalitis virus (CAEV) is a lentivirus that infects both goats and sheep and is closely related to maedi-visna virus that infects sheep; collectively, these viruses are known as small ruminant lentiviruses (SRLV). Infection of goats and sheep with SRLV typically results in discrete inflammatory diseases which include arthritis, mastitis, pneumonia or encephalomyelitis. SRLV-infected animals concurrently demonstrating lentivirus-associated lesions in tissues of lung, mammary gland, joint synovium and the central nervous system are either very rare or have not been reported. Here we describe a novel CAEV promoter isolated from a sheep with multisystemic lentivirus-associated inflammatory disease including interstitial pneumonia, mastitis, polyarthritis and leukomyelitis. A single, novel SRLV promoter was cloned and sequenced from five different anatomical locations (brain stem, spinal cord, lung, mammary gland and carpal joint synovium), all of which demonstrated lesions characteristic of lentivirus associated inflammation. This SRLV promoter isolate was found to be closely related to CAEV promoters isolated from goats in northern California and other parts of the world. The promoter was denoted CAEV-ovine-MS (multisystemic disease); the stability of the transcription factor binding sites within the U3 promoter sequence are discussed.
Caprine arthritis encephalitis virus (CAEV) is a pathogenic lentivirus in the family Retroviridae that infects both goats (genus Capra) and sheep (genus Ovis) and is closely related to the maedi-visna virus (MVV) of sheep [1,2]. CAEV and MVV are collectively classified as small ruminant lentiviruses (SRLV) that cause multiple progressive and debilitating inflammatory disease syndromes . SRLV infect and integrate into cells of the monocyte/macrophage lineage and dendritic cells [4,5], but unlike the immunodeficiency-causing lentiviruses, do not infect lymphocytes. SRLV infections are characterized by four chronic inflammatory disease syndromes-arthritis, mastitis, interstitial pneumonia, and encephalitis/myelitis [3,6,7]. It is presently acknowledged that under natural conditions, interspecies SRLV transmissions regularly occur in both directions, from sheep to goat and goat to sheep . Chronic progressive arthritis (caprine arthritis) is the most clinically relevant consequence of CAEV infection in goats and generally manifests in adult animals. The neurologic variant is less commonly diagnosed, tends to occur in 2–6 month old goat kids, and is the disease syndrome initially described for CAEV [9,10,11,12]. Neurologically affected goat kids exhibit paraparesis that eventually progresses to tetraparesis .
Polytropic SRLV infections are rare: this is particularly true for intercurrent articular and neurologic manifestations of disease. In a study examining natural CAEV-infection in 18 goats, infected kids demonstrating encephalomyelitis often demonstrated concurrent interstitial pneumonia, while adult goats with caprine arthritis demonstrated lesions of interstitial pneumonia but generally not concurrent encephalomyelitis . Mammary gland lesions were either not identified or were not reported. In an early paper describing experimental inoculation of goats with CAEV, neurologic lesions were often found to be associated with pulmonary lesions . In a more recent study of 22 naturally CAEV-infected goats, only three animals demonstrated CAEV-associated histological lesions in two tissues (e.g., lung and brain or lung and joint synovium), while most animals manifested lesions in a single tissue . For sheep, SRLV-associated articular joint lesions are not commonly identified, examined or reported. CAEV-infected animals concurrently demonstrating SRLV-associated lesions in tissues of the central nervous system, lung, mammary gland and joint synovium have not been reported.
At present, the reasons why SRLV demonstrate varied tissue tropisms in different animals have not yet been fully elucidated and may involve both host and virological factors. Viral tissue and cellular tropism can be influenced by the viral promoter and/or viral envelope coat protein (Env). In lentiviruses, the viral promoter is encoded within the U3 region of the long terminal repeats (LTR). In lentiviruses such as MVV and the human immunodeficiency virus-1 (HIV-1), the LTR has been shown to influence neural cytotropism [14,15]. While some nucleotide motifs within the CAEV U3 promoter region are conserved across viral strains, multiple mutations within the viral promoter have been identified in field isolates, some of which have been shown to affect tissue tropism and disease pathogenesis for other retroviruses [14,15,16]. The promoter of the ovine Jaagsiekte Sheep Retrovirus (JSRV) has been shown to be preferentially active in pulmonary type II pneumocytes and Clara cells, thereby defining viral tissue tropism and gene expression . Envelope glycoproteins may also play a role in cellular host range, infectivity, and disease progression. In the CAEV envelope surface glycoprotein (SU), previous studies have described five major regions of sequence diversity (V1–V5) between strains . Whether or not nucleotide sequence variation in CAEV SU plays a deterministic role in viral tropism has not been determined.
In this study, a recumbent blackface ewe was found to have clinically relevant multisystemic inflammatory disease including mastitis, pneumonia, polyarthritis and encephalomyelitis. An SRLV‑infection most consistent with CAEV was confirmed by serology, lesions histologically consistent with SRLV infection in the brain stem, spinal cord, lung, mammary gland and joint synovium, positive immunohistochemistry assays for SRLV (lung, brain stem and spinal cord), and amplification, cloning and sequencing of the same CAEV proviral promoter from all five infected tissues. The possible relationship of the U3 promoter sequence to disease pathogenesis is discussed.
2.1. Pathology and Immunohistochemistry
Grossly, the ovine lungs were diffusely reddish-pink with a uniform spongy texture and multiple, rare, small firm tan nodules embedded within the subpleural parenchyma on the dorsal-caudal aspect of the pulmonary lobes. The tissue over the anterior surface of the carpal joints was thickened, tan to white in color and had a firm texture. The carpal joint capsules were mildly congested. The carpal joints contained a normal amount of clear light yellow joint fluid. The stifle joints, brain and the spinal cord were grossly unremarkable. Gross lesions in the mammary gland were not described.
The lung, mammary gland, brain stem, spinal cord and carpal synovial joints exhibited histological lesions that were consistent with SRLV infection. The lesions in the brain stem (medulla oblongata) were characterized by scattered foci of spongiosis and vacuolation within the lateral white matter tracts. Within these regions, vessels were cuffed by lymphocytes and smaller numbers of macrophages. Spheroids, dilated axonal sheaths and numerous infiltrating glial cells were frequently identified. Within the medulla oblongata, multiple neurons within the vagal nucleus had intracytoplasmic vacuoles. The white matter of the thalamus, mid brain, and cerebellum had multifocal mixed mononuclear inflammatory cell infiltrates. Randomly throughout the cervical, thoracic and lumbar segments of the spinal cord were moderately sized foci of mononuclear inflammation in the peripheral white matter. These white matter lesions had a consistent pattern characterized by multifocal discrete wedge-shaped foci in which there was axonal degeneration, swelling and loss with replacement by markedly vacuolated neuropil containing numerous plump gitter cells. Within these inflamed foci, multiple vessels were cuffed by moderate numbers of mixed mononuclear inflammatory cells consisting of macrophages and small lymphocytes (leukomyelitis, multifocal, chronic, mononuclear, moderate, Figure 1a). Mammary gland lesions were histologically characterized by widespread glandular atrophy, pronounced interstitial fibrosis and prominent infiltrates of lymphocytes and fewer macrophages centered on remnant glands and ducts (mastitis, fibrosing, diffuse, chronic, lymphocytic, moderate, Figure 1b). Mononuclear infiltrates within the parenchyma of the mammary gland often formed coalescing follicle-like structures. Lymphocytes multifocally infiltrated and obscured the glandular and ductular epithelium. The lungs had diffuse atelectasis and numerous large, irregularly shaped perivascular lymphoid aggregates (interstitial pneumonia, diffuse, chronic, lymphocytic, marked with widespread lymphoid follicle formation, Figure 1c). Lymphoid aggregates often extended into, coalesced and obscured the adjacent pulmonary parenchyma. Peribronchiolar glands were variably distended with mucinous secretions. Synovial lesions (carpi) were characterized by hypertrophy and hyperplasia of synoviocytes, mild to moderate subsynovial infiltration of mixed mononuclear cells (lymphocytes and fewer macrophages), subsynovial vascular proliferation and pronounced villous hyperplasia (polyarthritis, lymphocytic, mild, Figure 1d).
In the immunohistochemically-stained tissues, intrahistiocytic CAEV Gag antigen expression was multifocally identified as intense cytoplasmic red-brown granules. Illustrative sections of the CNS and pulmonary tissues immunohistochemically positive for CAEV expression are shown in Figure 1a,c. Although all five of the ovine tissues had lesions histologically consistent with SRLV infection, only the spinal cord, brain stem and the lungs were immunohistochemically positive for CAEV antigen expression; the lung demonstrated the most robust IHC positivity.
2.2. Sequencing and Phylogenetic Analysis
For the initial PCR (pre-nested), amplicons of the CAEV U3 region were not evident on agarose gel electrophoresis except for the sample derived from the lung (data not shown). Appropriately-sized nested PCR amplicons were evident in samples isolated from all five of the sampled ovine tissues and not in the 2 no-template control samples (Figure 2). A single, unique CAEV proviral U3 sequence was amplified from proviral DNA extracted from the lung, mammary gland, brain stem, spinal cord and carpal synovial tissue. The proviral U3 sequence was named CAEV-ovine-MS to indicate the type of lentivirus, mammalian host and the fact that the isolate was associated with multisystemic disease (MS). MVV-specific nested PCR amplification yielded no amplicons. The amplification of CAEV envelope was not successful.
Previously, a CAEV U3 consensus sequence was derived from 41 distinct CAEV promoters regions isolated from 24 northern California goats . Relative to the CAEV U3 consensus sequence, 11 single nucleotide polymorphisms (SNPs) and a single 9 bp insertion were present in CAEV-ovine-MS (Figure 3).
In general, the U3 SNPs in CAEV-ovine-MS fall outside of the known transcription factor binding sites, except for the TAS (3 SNPs) and the three distal AP-1 sites. The 5' invariant TG, first and second AP-1 sites, GAS, IRF1, AML, both AP-4 sites and the TATA box are all absolutely conserved. A SNP (1 bp insertion) at position 184 generated the third AP-1 site. The nucleotide sequence of the viral U3 region has been deposited in the GenBank database under the accession number KF233596. Phylogenetic analysis revealed that CAEV-ovine-MS was related to other CAEV LTR sequences, derived from viruses isolated not only in California, but also in Mexico (FESC-752), in China (Gansu and Shanxi) and in other parts of the world (Figure 4).
In this study, we report the discovery of a unique SRLV U3 promoter from a sheep with multisystemic inflammatory disease characterized by intercurrent mastitis, pneumonia, polyarthritis and encephalomyelitis. Importantly, SRLV-infected sheep concurrently demonstrating SRLV‑associated lesions in tissues of the central nervous system, lung, mammary gland and joint synovium have not been previously reported. In a GenBank database search, the SRLV promoter was determined to be closely related to CAEV promoter isolates from northern California goats (Figure 4).
Attempts to amplify the lentiviral promoter using MVV specific degenerate primers and nested PCR were not successful, consistent with the CAEV designation. (Data not shown.)
Some of the histological lesions in the medulla oblongata (intracytoplasmic vacuolations) were suggestive of a transmissible spongiform encephalopathy (i.e., scrapie). For this reason, tissue samples were sent to the National Veterinary Services Laboratories (Ames, Iowa). Negative scrapie IHC assays (medulla oblongata, retropharyngeal lymph node and tonsil) eliminated transmissible spongiform encephalopathy as a differential diagnosis. Due to the joint lesions, an infection with Mycoplasma was also suspected, but the carpal joint tissues were negative when cultured for this agent. Although alveolar proteinosis is considered to be a “classic” histologic change often associated with pulmonary lentivirus infections, in our experience, it is not always present.
Although all of the examined tissues exhibited inflammatory lesions consistent with lentiviral infection, the presence of SRLV antigen within the tissues was confirmed by IHC assay only in the lung and tissues of the central nervous system (brain stem and spinal cord). Immunohistochemistry is known to have a reduced sensitivity relative to PCR, likely due to differential degradation rates of proteins relative to genomic DNA. IHC-based SRLV antigen detection has been reported to be compromised in samples derived from archived formalin-fixed tissue blocks ; tissue paraffin blocks used in this study were approximately 12 years old.
The sequence of the amplified CAEV U3 promoter was identical in all the affected tissues. Proviral SRLV U3 sequence variation of isolates obtained from different tissues from a single ruminant host has only rarely been reported [13,19]. Previous studies have documented minimal to modest CAEV U3 sequence variation between different anatomical sites [13,19]. In the case reported here, absolute U3 sequence conservation across multiple tissues suggests that the sequence of the viral promoter does not play a direct role in tissue tropism. This same conclusion has been reached previously . BLAST (NCBI) results revealed that although the promoter sequence is unique, it is most closely related to previously reported CAEV promoter sequences from northern California goats , consistent with the geographic location of the affected sheep described in this report. Presently, CAEV-infected goats from this geographic location are sporadically submitted for necropsy at the University of California, School of Veterinary Medicine or the California Animal Health and Food Safety Laboratory System (CAHFS). However, other U3 sequences corresponding to Mexican (FESC-752, GenBank Accession Number HM210570.1), Chinese (Gansu, GenBank Accession Number AY900630; Shanxi, GenBank Accession Number GU120138) or SRLV isolates reported by Israeli researchers (GenBank Accession Numbers M63106, X64109, X64828) also showed a high degree of homology with CAEV-ovine-MS. The initial age of infection, the extent of the infection within the herd and whether or not the sheep were mixed with clinically or subclinically affected goats are all factors that could affect the transmission of the CAEV from goats to sheep. Unfortunately, information regarding these possible scenarios is not available. Since the SRLV Env sequence may affect viral tissue tropism, an unsuccessful attempt was made to amplify the 3'portion of the CAEV env gene through PCR. Failure to amplify the CAEV env gene may be related to sequence variation (e.g., inappropriate amplification primers) or to degradation/fragmentation of the proviral DNA. In an attempt to address the former problem, the reverse primer (CAEVenv rev) was designed to anneal to the previously cloned and sequenced 3' region of env while the forward primer (CAEVTM/SU) was designed at the conserved interface between the TM and SU portion of env . Relative to a CAEV proviral consensus sequence derived from CAEV infected goats from northern California, multiple SNPs are present within the CAEV-ovine-MS U3 sequence. Most of these SNPs fall outside of the reported transcription factor binding domains, with the exception of TAS and the distal AP-1 sites. These results are generally consistent with previous findings demonstrating that the TAS and the fourth AP-1 site are the least conserved transcriptional features of the CAEV U3 region [13,21]. The presence of mutations in the regions between the known transcription factor binding sites suggests that these loci exhibit a higher level of mutational tolerance. The relevance of the 9 bp insertion (5' GCATAGGCC) at nucleotide locus 84–92 is not determined. Nucleotide insertions of varying lengths have been identified at this CAEV U3 locus previously in isolates from different parts of the world and do not seem to associate with any particular host tropism [13,21]. No putative transcription factor binding domains were identified within this 9 bp region in a transcription factor binding site search . It is possible that the 9 bp insertion in U3 functions as a “spacer” to appropriately position transcription factors within the transcriptional complex. A single nucleotide insertion at position 184 generated the third AP-1 site. The relevance of this mutation to viral transcription and tropism is currently unknown.
4. Materials and Methods
4.1. Signalment and Pathology
In 2001, a 79 kg, four year old blackface ewe sheep from a northern California flock with a 2–3 week history of neurologic deficits and bilateral carpal joint effusion was examined at the California Animal Health and Food Safety Laboratory System (CAHFS), University of California, Davis, CA, USA. The ewe was in thin body condition and the neurological deficits progressed to recumbency just prior to presentation. The sheep was humanely euthanized at the owner’s request and a complete necropsy was performed at the Davis CAHFS laboratory. A complete set of tissues including lung, joint synovium, mammary gland, brain, brain stem and spinal cord were obtained during the gross necropsy examination; any gross abnormalities were documented at the time of the necropsy examination. Tissues were promptly fixed in 10% buffered formalin for a minimum of 48 hours, trimmed, embedded in paraffin and routinely processed for histological examination. All of the tissues were examined by board certified veterinary pathologists (BB and BM).
4.2. Immunohistochemistry and Serology
Assessment of the SRLV serologic status was performed with the Small Ruminant Lentivirus Antibody Test Kit, cELISA (VMRD Inc, Pullman, WA, USA), according to manufacturer’s instructions. Immunohistochemistry (IHC) assays were utilized to determine the presence or absence of SRLV p28 Gag antigen in multiple formalin-fixed ovine tissues with lesions histologically consistent with SRLV infection. Tissues from a single SRLV-seronegative sheep lacking both gross and histological lesions were processed in parallel as a negative control for IHC assays.
The SRLV IHC assay utilized a primary monoclonal antibody with demonstrated reactivity to tissue-based CAEV group specific antigen (Gag) (CAEP10A1; VMRD) . In addition to anti‑CAEV antibodies, the SRLV ELISA test from which this monoclonal antibody was derived (Small Ruminant Lentivirus Antibody Test Kit, VMRD Inc, Pullman, WA, USA) has been shown to effectively detect antibodies to MVV in ovine serum with high sensitivity and specificity . The IHC assay was performed at the CAHFS laboratory, Davis, CA, USA.
Briefly, 5 μM thick paraffin-embedded tissue sections were cut and mounted on positively charged slides. After overnight air-drying, the slides were de-paraffinized and rehydrated using xylene and graded alcohols. Following a 100% alcohol step to block endogenous peroxidases, the slides were treated with 3% hydrogen peroxide in methanol and placed in 1× retrieval solution (Antigen Decloaker 10×, Biocare Medical, Concord, CA, USA) and autoclaved at 120 °C for 10 min. The slides were then rinsed in deionized water followed by TBS-Tween buffer. A blocking agent (0.5% casein in TBS‑Tween) was applied to the slides and incubated for 10 min at 25 °C. Without rinsing the slides, the CAEV10A1 primary antibody (VMRD) diluted 1:250 in 1% casein-TBS-Tween buffer or diluted 1:250 in normal mouse IgG was applied to the slides and incubated for 60 min at 25 °C. Subsequently, the slides were rinsed 3 times with TBS-Tween buffer followed by a 1:200 biotinylated goat anti‑mouse IgG secondary antibody (BA-9200, Vector Laboratories, Burlingame, CA, USA) incubated on the slides at 25 °C for 30 min. The slides were rinsed three times with TBS-Tween buffer and incubated with premixed ABC-HRP reagent (Vectastain Elite, Standard kit, PK-6100; Vector Laboratories) for 30 min at 25 °C. After rinsing three times with TBS-Tween buffer, the slides were then incubated with AEC (AEC Substrate Chromogen, Ready-to-Use, K3464; Dako Inc, Carpinteria, CA 93013, USA) for 10 min at 25 °C. The slides were rinsed in TBS-Tween, followed by deionized water, counterstained with Mayer’s hematoxylin and rinsed in deionized water. Aqueous mounting medium was applied and allowed to harden and coverslipped with permanent mounting medium. The IHC stains were performed in parallel with known positive and negative control tissues (tissues previously determined to be positive or negative via appropriate serology and histology) and an irrelevant isotype-control antibody as the negative control. Additional IHC assays performed included Neospora (spinal cord, CAHFS, University of California, Davis, CA, USA) , Sarcocystis neurona (spinal cord, CAHFS, University of California, Davis, CA, USA)  and scrapie prion protein (eyelid, tonsil, retropharyngeal lymph node, National Veterinary Services Laboratories, Ames, IA, USA) .
4.3. Molecular Techniques
Genomic DNA was extracted from multiple formalin-fixed paraffin-embedded tissues (brain stem, spinal cord, lung, mammary gland and carpal joint synovial tissue). Briefly, two 25 μM thick paraffin‑tissue scrolls were obtained from each of the five paraffin-embedded tissue blocks. In order to prevent cross contamination between samples, microtome blades were changed between samples. DNA was isolated and purified through the use of a commercial DNA extraction kit (QIAamp DNA FFPE tissue kit, Qiagen, Valencia, CA, USA). The nucleic acid concentration was assessed via spectrophotometry.
A nested polymerase chain reaction protocol was utilized to amplify a portion of the SRLV proviral 3' LTR. For both the CAEV and MVV primer sets, the forward primer sequence was located within the 3' aspect of the env reading frame, while the reverse primer was within the R region of the 3' LTR. Primary PCR was performed using conserved primers flanking the proviral CAEV U3 region in the 3'‑LTR: Revfor: 5'-CTGACGATGGGAATCTGG and R2rev: 5'-CTCGGTACCTCCTCGGAGAGGAGAG (predicted amplicon size of 334 bp ). Primer sequences were based upon regions of the CAEV-CO molecular clone (Cork isolate, GenBank Accession number M33677). For the primary amplification of the proviral MVV promoter, PCR was performed with degenerate primers flanking the proviral MVV U3 region in the 3'-LTR: MVV LTRfor: 5'-GCARTGGWKGGARGASAATGG and MVV LTRrev: WKYAGYCAACTCCTTTATTGAGSY (where M = A or C; R = G or A; K = G or T; W = A or T; S = C or G; and Y = T or C; D= A or G or T; Y= C or T). The MVV primers were designed based upon common features of four MVV GenBank sequences (M10608, NC_001452, L06906 and M60610).
The primary polymerase chain reaction was performed in a 100 μL total reaction volume with approximately 200–300 ng tissue-extracted DNA. The PCR reaction conditions were optimized utilizing a Mastercycler Gradient Thermocycler (Eppendorf). Reaction conditions for both CAEV and MVV-specific amplifications were as follows: an initial 95 °C stage for 2 min followed by 50 cycles at 95 °C for 15 s, 56 °C for 30 s, 72 °C for 30 s with a final extension period at 72 °C for 5 min. Water was used as a no-template control. PCR products were visualized on UV light-illuminated 1% agarose gels containing ethidium bromide.
In the event that no PCR amplicons were identified through agarose gel electrophoresis of the primary PCR, a nested PCR procedure was performed using 5 μL of the primary PCR amplicon as a template. Degenerate primers for the nested reaction were based upon conserved regions within the CAEV env gene (forward primer) and R region of the LTR (reverse primer). These degenerate primers were designed to fall within the amplified sequence of the primary PCR. The sequence of the forward and reverse nested primers for CAEV were CAEV nested LTR for: 5' TAAATGGAMRGCKTGGAGAACACCWC and CAEV nested LTR rev: 5' CTAGGAGSRMSTCTCCYAGAACTC, respectively (predicted amplicon size of 290 bp ). The sequence of the forward and reverse nested primers for MVV were MVVLTR Nest for: 5' TGGMGWRMDYMRSMDCAAAAAKAAA and MVVLTR Nest rev: 5' YYYMRSRCAGGCAGGAGAG, respectively. Nested PCR conditions were the same as for the initial PCR, except that 30 cycles of amplification were performed and the annealing temperature was set at 59 °C for the CAEV and 53 °C for the MVV. The no-template (water) control sample was carried forward in parallel from the primary PCR reaction.
An attempt was made to amplify the 3' portion of the proviral CAEV env gene from the tissue sections. Primers were designed based on conserved regions within the envelope gene of CAEV-CO . The forward primer spans the surface envelope transmembrane region: CAEVTM/SUfor 5' gccacaagaggaagaagagaggc  and the reverse primer spans through the 3' end of the envelope: CAEVenv rev 5' gaggtgttctccacgccgtccattta. The CAEVenv rev primer was designed to code for the non-degenerate, reverse sequence of CAEV nested LTR for; predicted amplicon size of approximately 850 bp. Reaction conditions were as follows: an initial 95 °C stage for 2 min followed by 50 cycles at 95 °C for 15 s, 56 °C for 30 s, 72 °C for 2 min with a final extension period at 72 °C for 5 min.
Multiple precautions were taken to prevent sample cross-contamination or environmental contamination of nucleic acids by utilizing centrifuges, pipettes and plasticware on a bench space dedicated solely to the isolation of nucleic acids (i.e., free of plasmid DNA). All sterile pipette tips and plasticware were single-use and certified to be free of nucleic acids and enzyme contamination (Eppendorf, Hauppauge, NY, USA). The PCR reactions were set up in an isolated room dedicated to this purpose using sterilizing PCR workstations (UVP, Upland, CA, USA). The workstation surfaces were treated for 30 min prior to use with a chemical enzymatic solution (DNAzap, Ambion, Austin, TX, USA). Workstations were exposed to 15–30 min of UV light before and after each use.
Amplicons of the predicted size were purified using a commercial kit (Microcon, Millipore, Billerica, MA, USA) and were cloned using the TA Cloning Kit (Invitrogen, Grand Island, NY, USA), according to the manufacturer’s instructions. For each sample, six bacterial clones were selected, cultured overnight and the plasmid DNA isolated using a commercial kit (Wizard Plus SV Minipreps, Promega, Madison, WI, USA). For each clone, the size of the PCR product inserts were first verified by restriction endonuclease digestion; plasmid clones with the correctly-sized inserts were then submitted for sequencing through a local vendor (Davis Sequencing, Davis, CA, USA).
4.4. Phylogenetic and Transcription Factor Analyses
Viral U3 promoter nucleotide sequences were aligned and phylogenetically compared using the AlignX function of Vector NTI (Invitrogen, Carlsbad, CA, USA). Align X calculations for generating the guide tree dendrogram are based on Clustal W algorithm . Phylogenetic trees were obtained using ClustalW2  and TreeView .
In conclusion, we have identified a novel CAEV promoter isolated from a sheep with multisystemic lentivirus-associated inflammatory disease including interstitial pneumonia, mastitis, polyarthritis and leukomyelitis. A single, novel SRLV promoter, denoted CAEV-ovine-MS, was cloned and sequenced from five different anatomical locations (brain stem, spinal cord, lung, mammary gland and carpal joint synovium), all of which demonstrated lesions characteristic of lentivirus associated inflammation.
Conflict of Interest
The authors declare no conflict of interest.
The authors wish to thank Chad Hillman for technical assistance and K. Murphy for editing of the manuscript. We are grateful for the histologic expertise provided by the UC Davis Histopathology Laboratory. This study was supported by grants from both the American Dairy Goat Association Research Foundation and Federal Hatch funds provided by the UC Davis School of Veterinary Medicine’s Center for Food Animal Health (CFAH).
References and Notes
- Benavides, J.; Garcia-Pariente, C.; Fuertes, M.; Ferreras, M.C.; Garcia-Marin, J.F.; Juste, R.A.; Perez, V. Maedi-visna: The meningoencephalitis in naturally occurring cases. J. Comp. Pathol. 2009, 140, 1–11, doi:10.1016/j.jcpa.2008.07.010.
- Fields Virology, 4th ed.; Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, A.M., Roizman, B., Straus, E.S., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2001.
- Maxie, M.G.; Jubb, K.V.F. Pathology of Domestic Animals, 5th ed. ed.; Elsevier Saunders: Edinburgh ; New York, NY, USA, 2007.
- Zink, M.C.; Yager, J.A.; Myers, J.D. Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats. Am. J. Pathol. 1990, 136, 843–854.
- Ryan, S.; Tiley, L.; McConnell, I.; Blacklaws, B. Infection of dendritic cells by the Maedi-Visna lentivirus. J. Virol. 2000, 74, 10096–10103, doi:10.1128/JVI.74.21.10096-10103.2000.
- Kennedy-Stoskopf, S.; Zink, M.C.; Jolly, P.E.; Narayan, O. Lentivirus-induced arthritis. Chronic disease caused by a covert pathogen. Rheum. Dis. Clin. North. Am. 1987, 13, 235–247.
- Benavides, J.; Fuertes, M.; Garcia-Pariente, C.; Otaola, J.; Delgado, L.; Giraldez, J.; Garcia Marin, J.F.; Carmen Ferreras, M.; Perez, V. Impact of maedi-visna in intensively managed dairy sheep. Vet. J. 2013, doi:10.1016/j.tvjl.2013.03.031.
- Rachid, A.; Croise, B.; Russo, P.; Vignoni, M.; Lacerenza, D.; Rosati, S.; Kuzmak, J.; Valas, S. Diverse host-virus interactions following caprine arthritis-encephalitis virus infection in sheep and goats. J. Gen. Virol. 2013, 94, 634–642, doi:10.1099/vir.0.044768-0.
- Cork, L.C. Differential diagnosis of viral leukoencephalomyelitis of goats. J. Am. Vet. Med. Assoc. 1976, 169, 1303–1306.
- Cork, L.C.; Davis, W.C. Ultrastructural features of viral leukoencephalomyelitis of goats. Lab. Invest. 1975, 32, 359–365.
- Cork, L.C.; Hadlow, W.J.; Crawford, T.B.; Gorham, J.R.; Piper, R.C. Infectious leukoencephalomyelitis of young goats. J. Infect. Dis. 1974, 129, 134–141, doi:10.1093/infdis/129.2.134.
- Cork, L.C.; Hadlow, W.J.; Gorham, J.R.; Piper, R.C.; Crawford, T.B. Pathology of viral leukoencephalomyelitis of goats. Acta Neuropathol. 1974, 29, 281–292, doi:10.1007/BF00685482.
- Murphy, B.; McElliott, V.; Vapniarsky, N.; Oliver, A.; Rowe, J. Tissue tropism and promoter sequence variation in caprine arthritis encephalitis virus infected goats. Virus Res. 2010, 151, 177–184, doi:10.1016/j.virusres.2010.05.002.
- Agnarsdottir, G.; Thorsteinsdottir, H.; Oskarsson, T.; Matthiasdottir, S.; Haflidadottir, B.S.; Andresson, O.S.; Andresdottir, V. The long terminal repeat is a determinant of cell tropism of maedi-visna virus. J. Gen. Virol. 2000, 81, 1901–1905.
- Barros, S.C.; Andresdottir, V.; Fevereiro, M. Cellular specificity and replication rate of Maedi Visna virus in vitro can be controlled by LTR sequences. Arch. Virol. 2005, 150, 201–213, doi:10.1007/s00705-004-0436-2.
- Ross, H.L.; Gartner, S.; McArthur, J.C.; Corboy, J.R.; McAllister, J.J.; Millhouse, S.; Wigdahl, B. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J. Neurovirol. 2001, 7, 235–249, doi:10.1080/13550280152403281.
- Palmarini, M.; Datta, S.; Omid, R.; Murgia, C.; Fan, H. The long terminal repeat of Jaagsiekte sheep retrovirus is preferentially active in differentiated epithelial cells of the lungs. J. Virol. 2000, 74, 5776–5787, doi:10.1128/JVI.74.13.5776-5787.2000.
- Valas, S.; Benoit, C.; Baudry, C.; Perrin, G.; Mamoun, R.Z. Variability and immunogenicity of caprine arthritis-encephalitis virus surface glycoprotein. J. Virol. 2000, 74, 6178–6185, doi:10.1128/JVI.74.13.6178-6185.2000.
- Murphy, B.; Hillman, C.; Castillo, D.; Vapniarsky, N.; Rowe, J. The presence or absence of the gamma-activated site determines IFN gamma-mediated transcriptional activation in CAEV promoters cloned from the mammary gland and joint synovium of a single CAEV-infected goat. Virus Res. 2012, 163, 537–545, doi:10.1016/j.virusres.2011.12.001.
- Knowles, D.P., Jr.; Cheevers, W.P.; McGuire, T.C.; Brassfield, A.L.; Harwood, W.G.; Stem, T.A. Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis-encephalitis lentivirus. J. Virol. 1991, 65, 5744–5750.
- Gomez-Lucia, E.; Rowe, J.; Collar, C.; Murphy, B. Diversity of caprine arthritis-encephalitis virus promoters isolated from goat milk and passaged in vitro. Vet. J. 2013, 196, 431–438, doi:10.1016/j.tvjl.2012.10.023.
- Transcription Factor Search. Available online: http://www.cbrc.jp/research/db/TFSEARCH.html/ (accessed on 22 June 2013).
- Herrmann, L.M.; Cheevers, W.P.; Marshall, K.L.; McGuire, T.C.; Hutton, M.M.; Lewis, G.S.; Knowles, D.P. Detection of serum antibodies to ovine progressive pneumonia virus in sheep by using a caprine arthritis-encephalitis virus competitive-inhibition enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 2003, 10, 862–865.
- Pescador, C.A.; Corbellini, L.G.; Oliveira, E.C.; Raymundo, D.L.; Driemeier, D. Histopathological and immunohistochemical aspects of Neospora caninum diagnosis in bovine aborted fetuses. Vet. Parasitol. 2007, 150, 159–163, doi:10.1016/j.vetpar.2007.08.028.
- Hamir, A.N.; Moser, G.; Galligan, D.T.; Davis, S.W.; Granstrom, D.E.; Dubey, J.P. Immunohistochemical study to demonstrate Sarcocystis neurona in equine protozoal myeloencephalitis. J. Vet. Diagn. Invest. 1993, 5, 418–422, doi:10.1177/104063879300500320.
- Monleon, E.; Monzon, M.; Hortells, P.; Bolea, R.; Acin, C.; Vargas, F.; Badiola, J.J. Approaches to Scrapie diagnosis by applying immunohistochemistry and rapid tests on central nervous and lymphoreticular systems. J. Virol. Methods 2005, 125, 165–171, doi:10.1016/j.jviromet.2005.01.013.
- Thompson, J.D.; Higgins, D.G.; Gibson, T.J. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22, 4673–4680, doi:10.1093/nar/22.22.4673.
- Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; McGettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23, 2947–2948, doi:10.1093/bioinformatics/btm404.
- Page, R.D. TreeView: An application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 1996, 12, 357–358.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).